Clinical Trials Browser

Breast Adenocarcinoma × Clear all

NCT00433511 2026-03-03

Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

Phase 3 Active not recruiting

4,994 enrolled 11 charts

Breast Adenocarcinoma

NCT04517838 2025-12-24

Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer

Breast Adenocarcinoma

NCT05447910 2025-06-15

Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer

Breast Adenocarcinoma

NCT06977412 2025-05-18

The Application Value of Spectral CT in the Accurate Staging of Breast Cancer

Phase NA Not yet recruiting

Breast Adenocarcinoma

NCT06671262 2025-02-11

NEOTRIO-HR

Phase 2 Recruiting

Breast Adenocarcinoma

NCT06805084 2025-02-03

H/ACA-ER

Active not recruiting

Breast Adenocarcinoma

NCT02282345 2022-07-06

Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer

Phase 2 Completed

36 enrolled 14 charts

Breast Adenocarcinoma